<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[lg electronics inc. and license agreement Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/lg+electronics+inc.+and+license+agreement.html?i=13]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to lg electronics inc. and license agreement]]></description>
	<s:counts start="0" returned="4" found="4" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Gilead and LG Life Sciences Announce Global License Agreement to Advance Novel Drug Candidates for Treatment of Fibrotic Diseases]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Nov_7/ai_n27435774]]></link>
		<description><![CDATA[FOSTER CITY, Calif. & SEOUL, South Korea -- Gilead Sciences, Inc. (Nasdaq:GILD) and LG Life Sciences, Ltd. LGLS today announced that the companies have entered into an exclusive license agreement focused on the development of caspase inhibitors for the treatment of fibrotic diseases. The agreement grants Gilead commercialization rights to...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 07 Nov 2007 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/agreement.html"><![CDATA[agreement]]></category>
		<category domain="http://resources.bnet.com/topic/lg+electronics+inc..html"><![CDATA[LG Electronics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/license+agreement.html"><![CDATA[license agreement]]></category>
		<category domain="http://resources.bnet.com/topic/life+science.html"><![CDATA[life science]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Oscient Pharmaceuticals Amends FACTIVE License Agreement with LG Life Sciences]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_Dec_29/ai_n27096537]]></link>
		<description><![CDATA[-- Amendment expands territories covered to include more than 40 European countries --]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 29 Dec 2006 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/lg+electronics+inc..html"><![CDATA[LG Electronics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/license+agreement.html"><![CDATA[license agreement]]></category>
		<category domain="http://resources.bnet.com/topic/life+science.html"><![CDATA[life science]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Nuance and LG Electronics Sign License Agreement for Nuance's Voice-Activated Dialing Patent]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_Oct_11/ai_n27041649]]></link>
		<description><![CDATA[Agreement Provides License to Nuance Technology for LG Phones Using Voice-Activated Dialing]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 11 Oct 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/lg+electronics+inc..html"><![CDATA[LG Electronics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/license+agreement.html"><![CDATA[license agreement]]></category>
		<category domain="http://resources.bnet.com/topic/nuance.html"><![CDATA[Nuance]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Oscient Pharmaceuticals and LG Life Sciences Amend FACTIVE License Agreement; Modifications include adjustments to royalty rate structure]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_April_6/ai_n13559125]]></link>
		<description><![CDATA[WALTHAM, Mass. -- Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) has amended its license and option agreement with LG Life Sciences, Ltd. for the Company's lead product, FACTIVER gemifloxacin mesylate tablets. The amended agreement includes a reduction of future royalties payable to LG Life Sciences at certain FACTIVE revenue levels in territories...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 06 Apr 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/adjustment.html"><![CDATA[adjustment]]></category>
		<category domain="http://resources.bnet.com/topic/lg+electronics+inc..html"><![CDATA[LG Electronics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/license+agreement.html"><![CDATA[license agreement]]></category>
		<category domain="http://resources.bnet.com/topic/life+science.html"><![CDATA[life science]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
</channel>
</rss>
